{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-088662","form_type":"8-K","ticker":"VYNE","cik":"0001566044","company_name":"VYNE Therapeutics Inc.","filed_at":"2026-07-30T20:03:20+00:00","discovered_at":"2026-07-30T20:04:00.830113+00:00","generated_at":"2026-07-30T20:04:08.334233+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Yarrow Bioscience exchanges shares for pre-funded warrants; warrant count dwarfs common shares","bullets":["Exchanged 133,290 common shares for pre-funded warrants to purchase same number at $0.0001/share.","After exchange: 2,669,788 common shares outstanding; 25,914,530 pre-funded warrants outstanding.","Warrants immediately exercisable, subject to 9.99% beneficial ownership limitation (can be increased to 19.99%).","Exchange closed July 29, 2026; issued under Section 3(a)(9) exemption from registration."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-088662","json":"https://secwatch.observer/filing/0001104659-26-088662.json","markdown":"https://secwatch.observer/filing/0001104659-26-088662.md","text":"https://secwatch.observer/filing/0001104659-26-088662.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926088662/0001104659-26-088662-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926088662/tm2621655d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T20:04:08.334233+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}